NeuroPace, Inc. provided earnings guidance for the year 2024. Total revenue to range between $73 million and $77 million, representing growth of 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.64 USD | -1.87% | +5.00% | +32.30% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Wells Fargo Upgrades NeuroPace to Overweight From Equalweight, Raises Price Target to $20 From $16 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.30% | 399M | |
+7.84% | 218B | |
+7.35% | 183B | |
+13.04% | 134B | |
+26.03% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.30% | 40.3B | |
+2.78% | 35.53B | |
+26.14% | 32.05B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- NeuroPace, Inc. Provides Earnings Guidance for the Year 2024